Donald Hooker
Stock Analyst at Keybanc
(2.53)
# 2,219
Out of 5,163 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $5.37 | +1,762.20% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $155.46 | +150.87% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $199.70 | -14.87% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $164.72 | +76.06% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $10.97 | +565.45% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $3.42 | +952.63% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $5.62 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $178.88 | +97.34% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $77.81 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $72.41 | +16.01% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.99 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $263.80 | -35.56% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $98.33 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $0.79 | +5,722.78% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $450.41 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $5.37
Upside: +1,762.20%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $155.46
Upside: +150.87%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $199.70
Upside: -14.87%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $164.72
Upside: +76.06%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $10.97
Upside: +565.45%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $3.42
Upside: +952.63%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $5.62
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $178.88
Upside: +97.34%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $77.81
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $72.41
Upside: +16.01%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $2.99
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $263.80
Upside: -35.56%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $98.33
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $0.79
Upside: +5,722.78%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $450.41
Upside: -